Profile
Joseph C.
DosSantos served as Chief Financial Officer at MYOS RENS Technology, Inc. from 2015 to 2016, at Luzsana Biotechnology, Inc. from 2021 to 2023, and at CareCloud, Inc. in 2023.
He received an undergraduate degree from Kean University in 1991 and an MBA from Seton Hall University.
Former positions of Joseph C. DosSantos
| Companies | Position | End |
|---|---|---|
| CARECLOUD, INC. | Director of Finance/CFO | 2023-05-09 |
Luzsana Biotechnology, Inc.
 Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Part of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Luzsana Biotechnology, Inc. is a biotechnology company that develops medicines. The private company is based in Princeton, NJ. | Director of Finance/CFO | 2023-05-07 |
| MEDAVAIL HOLDINGS, INC. | Chief Executive Officer | 2015-12-16 |
Training of Joseph C. DosSantos
| Kean University | Undergraduate Degree |
| Seton Hall University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CARECLOUD, INC. | Technology Services |
| Private companies | 2 |
|---|---|
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Part of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Luzsana Biotechnology, Inc. is a biotechnology company that develops medicines. The private company is based in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Joseph C. DosSantos
